3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
126
Breast Neoplasms
78
Neoplasms
48
Prostatic Neoplasms
19
Fatigue
16
Obesity
14
Colorectal Neoplasms
13
Lung Neoplasms
11
Polycystic Ovary Syndrome
10
Colonic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Weight Loss
6
Ovarian Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphedema
5
Leukemia
5
Inflammation
5
Pancreatic Neoplasms
4
Overweight
4
Multiple Endocrine Neoplasia Type 1
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Insulin Resistance
4
Depression
4
Cognitive Dysfunction
4
Brain Neoplasms
4
Stomach Neoplasms
3
Peripheral Nervous System Diseases
3
Interventions
halofantrine
2
Sorafenib
2
trifluridine tipiracil drug combination
1
trametinib
1
toripalimab
1
tislelizumab
1
sintilimab
1
rubitecan
1
repotrectinib
1
pevonedistat
1
pembrolizumab
1
ozanimod
1
lenvatinib
1
ledipasvir, sofosbuvir drug combination
1
gadolinium ethoxybenzyl DTPA
1
fisogatinib
1
ficlatuzumab
1
camrelizumab
1
belinostat
1
avelumab
1
Trabectedin
1
Shadowing Technique, Histology
1
Ramucirumab
1
Patient Navigation
1
Oxaliplatin
1
Nutritional Status
1
Nivolumab
1
Nadroparin
1
N-monoacetylcystine
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Liver Diseases
×
Exercise
×
Clear all
NCT04666558
2022-10-04
PiONEeR
University of Alberta
Phase NA
Completed
216 enrolled